The “birthplace of biotechnology” is to receive $10 million for a pioneering precision medicine programme.
It was announced this week that the California Initiative to Advance Precision Medicine (CIAPM) has been awarded the money from the local government’s budget, a decision welcomed by the California Life Sciences Association (CLSA).
Sara Radcliffe, President & CEO, CLSA, said: “California Life Sciences Association (CLSA) applauds Governor Jerry Brown, California State Senate and California Assembly leaders for their strong support of life sciences innovation, as demonstrated again in this year’s 2017-2018 budget deal which allocates a $10 million investment in precision medicine research. California is the birthplace of biotechnology and today the state’s life sciences sector employs over 287,200 people working to develop innovative new medicines, technologies and therapies needed to treat and cure patients.”
The Californian city of San Diego is hosting the BIO International Conventional – the global event for biotechnology – next week. It will celebrate the industry’s many breakthroughs and on going impact on society. It will take place at the San Diego Convention Center between 19 and 22 June.